Toll-like receptors signaling contributes to immunopathogenesis of HBV infection

Gastroenterology Research and Practice

Volumn , Issue , 2011, Pages

  Kondo, Yasuteru ^a   Ueno, Yoshiyuki ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALPHA INTERFERON; DNA VACCINE; DOUBLE STRANDED RNA; ENTECAVIR; FLAGELLIN; IMMUNOMODULATING AGENT; LAMIVUDINE; LIPOPROTEIN; MEMBRANE RECEPTOR; PROFILIN; PROTEIN VACCINE; SINGLE STRANDED RNA; T LYMPHOCYTE EPITOPE; TENOFOVIR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 12; TOLL LIKE RECEPTOR 13; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MEMBRANE; DENDRITIC CELL; DRUG EFFICACY; ENDOSOME; HEPATITIS B; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFECTION CONTROL; INNATE IMMUNITY; INTRACELLULAR SIGNALING; KUPFFER CELL; LIVER CELL; MONOCYTE; NATURAL KILLER CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; REVIEW; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION;

EID: 84855574261     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2011/810939     Document Type: Review

References (57)

1. Tiollais P., Pourcel C., Dejean A., The hepatitis B virus Nature 1985 317 6037 489 495 (Pubitemid 16224154)
2. Lai C. L., Ratziu V., Yuen M. F., Poynard T., Viral hepatitis B Lancet 2003 362 9401 2089 2094 (Pubitemid 38032767)
3. Chisari F. V., Ferrari C., Hepatitis B virus immunopathogenesis Annual Review of Immunology 1995 13 29 60
4. Kgi D., Ledermann B., Brki K., Zinkernagel R. M., Hengartner H., Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo Annual Review of Immunology 1996 14 207 232 (Pubitemid 26130183)
5. Reignat S., Webster G. J. M., Brown D., Ogg G. S., King A., Seneviratne S. L., Dusheiko G., Williams R., Maini M. K., Bertoletti A., Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection Journal of Experimental Medicine 2002 195 9 1089 1101 (Pubitemid 34517136)
6. Baron J. L., Gardiner L., Nishimura S., Shinkai K., Locksley R., Ganem D., Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection Immunity 2002 16 4 583 594 (Pubitemid 34442582)
7. Bonorino P., Ramzan M., Camous X., Dufeu-Duchesne T., Thélu M. A., Sturm N., Dariz A., Guillermet C., Pernollet M., Zarski J. P., Marche P. N., Leroy V., Jouvin-Marche E., Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C Journal of Hepatology 2009 51 3 458 467
8. Kakimi K., Guidotti L. G., Koezuka Y., Chisari F. V., Natural killer T cell activation inhibits hepatitis B virus replication in vivo Journal of Experimental Medicine 2000 192 7 921 930
9. Ju Y., Hou N., Meng J., Wang X., Zhang X., Zhao D., Liu Y., Zhu F., Zhang L., Sun W., Liang X., Gao L., Ma C., T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B Journal of Hepatology 2010 52 3 322 329
10. Kennedy P. T. F., Gehring A. J., Nowbath A., Selden C., Quaglia A., Dhillon A., Dusheiko G., Bertoletti A., The expression and function of NKG2D molecule on intrahepatic CD8 + T cells in chronic viral hepatitis Journal of Viral Hepatitis 2008 15 12 901 909
11. Kondo Y., Asabe S., Kobayashi K., Shiina M., Niitsuma H., Ueno Y., Kobayashi T., Shimosegawa T., Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity Journal of Medical Virology 2004 74 3 425 433 (Pubitemid 39281641)
12. Boni C., Penna A., Bertoletti A., Lamonaca V., Rapti I., Missale G., Pilli M., Urbani S., Cavalli A., Cerioni S., Panebianco R., Jenkins J., Ferrari C., Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B Journal of Hepatology 2003 39 4 595 605 (Pubitemid 37204661)
13. Kondo Y., Kobayashi K., Ueno Y., Shiina M., Niitsuma H., Kanno N., Kobayashi T., Shimosegawa T., Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B World Journal of Gastroenterology 2006 12 27 4310 4317 (Pubitemid 44194522)
14. Kondo Y., Ueno Y., Kobayashi K., Kakazu E., Shiina M., Inoue J., Tamai K., Wakui Y., Tanaka Y., Ninomiya M., Obara N., Fukushima K., Ishii M., Kobayashi T., Niitsuma H., Kon S., Shimosegawa T., Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes Journal of Infectious Diseases 2010 202 2 202 213
15. Cooper A., Tal G., Lider O., Shaul Y., Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2 Journal of Immunology 2005 175 5 3165 3176 (Pubitemid 41170538)
16. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity Cell 2006 124 4 783 801 (Pubitemid 43261452)
17. MacHida K., TLRs, alcohol, HCV, and tumorigenesis Gastroenterology Research and Practice 2010 2010 8
18. Saito T., Owen D. M., Jiang F., Marcotrigiano J., Gale M., Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA Nature 2008 454 7203 523 527
19. Visvanathan K., Skinner N. A., Thompson A. J. V., Riordan S. M., Sozzi V., Edwards R., Rodgers S., Kurtovic J., Chang J., Lewin S., Desmond P., Locarnini S., Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein Hepatology 2007 45 1 102 110 (Pubitemid 46150869)
20. Lang T., Lo C., Skinner N., Locarnini S., Visvanathan K., Mansell A., The Hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway Journal of Hepatology 2011 55 4 762 769
21. Yu S., Chen J., Wu M., Chen H., Kato N., Yuan Z., Hepatitis B virus polymerase inhibits RIG-I- and toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKK and DDX3 Journal of General Virology 2010 91 8 2080 2090
22. Wu J., Meng Z., Jiang M., Pei R., Trippler M., Broering R., Bucchi A., Sowa J. P., Dittmer U., Yang D., Roggendorf M., Gerken G., Lu M., Schlaak J. F., Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells Hepatology 2009 49 4 1132 1140
23. Kumar M., Jung S. Y., Hodgson A. J., Madden C. R., Qin J., Slagle B. L., Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon Journal of Virology 2011 85 2 987 995
24. Riordan S. M., Skinner N., Kurtovic J., Locarnini S., Visvanathan K., Reduced expression of Toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B Clinical and Vaccine Immunology 2006 13 8 972 974 (Pubitemid 44409640)
25. Tavakoli S., Mederacke I., Herzog-Hauff S., Glebe D., Grn S., Strand D., Urban S., Gehring A., Galle P. R., Bcher W. O., Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection Clinical and Experimental Immunology 2008 151 1 61 70 (Pubitemid 350230996)
26. Li N., Li Q., Qian Z., Zhang Y., Chen M., Shi G., Impaired TLR3/IFN- signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: relevance to the severity of liver damage Biochemical and Biophysical Research Communications 2009 390 3 630 635
27. Zhang Y., Lian J. Q., Huang C. X., Wang J. P., Wei X., Nan X. P., Yu H. T., Jiang L. L., Wang X. Q., Zhuang Y., Li X. H., Li Y., Wang P. Z., Robek M. D., Bai X. F., Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4 + CD25 + regulatory T cells in chronic hepatitis B virus infection Virology 2010 397 1 34 42
28. Wentworth P. A., Celis E., Crimi C., Stitely S., Hale L., Tsai V., Serra H. M., Del Guercio M. F., Livingston B., Alazard D., Fikes J., Kubo R. T., Grey H. M., Chesnut R. W., Chisari F. V., Sette A., In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides Molecular Immunology 1995 32 9 603 612
29. Rehermann B., Pasquinelli C., Mosier S. M., Chisari F. V., Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection Journal of Clinical Investigation 1995 96 3 1527 1534
30. Kondo Y., Kobayashi K., Asabe S., Shiina M., Niitsuma H., Ueno Y., Kobayashi T., Shimosegawa T., Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8 + T lymphocytes in fulminant hepatitis B Liver International 2004 24 6 561 567 (Pubitemid 40028607)
31. Frelin L., Wahlstrm T., Tucker A. E., Jones J., Hughes J., Lee B. O., Billaud J. N., Peters C., Whitacre D., Peterson D., Milich D. R., A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection Journal of Virology 2009 83 3 1379 1392
32. Maier H., Isogawa M., Freeman G. J., Chisari F. V., PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8 + T lymphocytes in the liver Journal of Immunology 2007 178 5 2714 2720 (Pubitemid 46333147)
33. Chisari F. V., Ferrari C., Hepatitis B virus immunopathology Springer Seminars in Immunopathology 1995 17 2-3 261 281
34. Wang J. P., Zhang Y., Wei X., Li J., Nan X. P., Yu H. T., Li Y., Wang P. Z., Bai X. F., Circulating toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C APMIS 2010 118 4 261 270
35. Lian J. Q., Wang X. Q., Zhang Y., Huang C. X., Bai X. F., Correlation of circulating TLR2/4 expression with CD3 + /4 + /8 + T cells and treg cells in HBV-related liver cirrhosis Viral Immunology 2009 22 5 301 308
36. Stoop J. N., Van Der Molen R. G., Baan C. C., Van Der Laan L. J. W., Kuipers E. J., Kusters J. G., Janssen H. L. A., Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection Hepatology 2005 41 4 771 778 (Pubitemid 40462939)
37. Nan X. P., Zhang Y., Yu H. T., Li Y., Sun R. L., Wang J. P., Bai X. F., Circulating CD4 + CD25high regulatory T cells and expression of PD-1 and BTLA on CD4 + T cells in patients with chronic hepatitis B virus infection Viral Immunology 2010 23 1 63 70
38. Li X., Chen Y., Ma Z., Ye B., Wu W., Li L., Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8 + T cells in patients with chronic hepatitis B virus infection Cellular Immunology 2010 264 1 42 46
39. Li J., Wu W., Peng G., Chen F., Bai M., Zheng M., Chen Z., HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients Immunology and Cell Biology 2010 88 8 834 841
40. Peng G., Li S., Wu W., Sun Z., Chen Y., Chen Z., Circulating CD4 + CD25 + regulatory T cells correlate with chronic hepatitis B infection Immunology 2008 123 1 57 65 (Pubitemid 350255997)
41. Yang G., Liu A., Xie Q., Guo T. B., Wan B., Zhou B., Zhang J. Z., Association of CD4 + CD25 + Foxp3 + regulatory T cells with chronic activity and viral clearance in patients with hepatitis B International Immunology 2007 19 2 133 140 (Pubitemid 46179008)
42. Zanin-Zhorov A., Cahalon L., Tal G., Margalit R., Lider O., Cohen I. R., Heat shock protein 60 enhances CD4 + CD25 + regulatory T cell function via innate TLR2 signaling Journal of Clinical Investigation 2006 116 7 2022 2032 (Pubitemid 44033326)
43. Schaub B., Campo M., He H., Perkins D., Gillman M. W., Gold D. R., Weiss S., Lieberman E., Finn P. W., Neonatal immune responses to TLR2 stimulation: influence of maternal atopy on Foxp3 and IL-10 expression Respiratory Research 2006 7, article 40
44. Kabelitz D., Wesch D., Oberg H. H., Regulation of regulatory T cells: role of dendritic cells and toll-like receptors Critical Reviews in Immunology 2006 26 4 291 305 (Pubitemid 44423548)
45. Guan R., Interferon monotherapy in chronic hepatitis B Journal of Gastroenterology and Hepatology 2000 15 E34 E40
46. Angus P., Vaughan R., Xiong S., Yang H., Delaney W., Gibbs C., Brosgart C., Colledge D., Edwards R., Ayres A., Bartholomeusz A., Locarnini S., Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase Gastroenterology 2003 125 2 292 297 (Pubitemid 36929407)
47. Liaw Y.-F., Leung N. W.Y., Chang T.-T., Guan R., Tai D.-I., Ng K.-Y., Chien R.-N., Dent J., Roman L., Edmundson S., Lai C.-L., Effects of extended lamivudine therapy in asian patients with chronic hepatitis B Gastroenterology 2000 119 1 172 180 (Pubitemid 30452590)
48. Ross R. S., Viazov S., Roggendorf M., Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B Journal of Medical Virology 2002 66 4 452 460 (Pubitemid 34203232)
49. Horsmans Y., Berg T., Desager J. P., Mueller T., Schott E., Fletcher S. P., Steffy K. R., Bauman L. A., Kerr B. M., Averett D. R., Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection Hepatology 2005 42 3 724 731 (Pubitemid 41233667)
50. Yang S. H., Lee C. G., Park S. H., Im S. J., Kim Y. M., Son J. M., Wang J. S., Yoon S. K., Song M. K., Ambrozaitis A., Kharchenko N., Yun Y. D., Kim C. M., Kim C. Y., Lee S. H., Kim B. M., Kim W. B., Sung Y. C., Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study Gene Therapy 2006 13 14 1110 1117
51. Kondo Y., Ueno Y., Shimosegawa T., Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies Clinical Journal of Gastroenterology 2009 2 2 71 79
52. Chang W. W., Su I. J., Lai M. D., Chang W. T., Huang W., Lei H. Y., Toll-like receptor 4 plays an anti-HBV role in a murine model of acute hepatitis B virus expression World Journal of Gastroenterology 2005 11 42 6631 6637 (Pubitemid 43072702)
53. Isogawa M., Robek M. D., Furuichi Y., Chisari F. V., Toll-like receptor signaling inhibits hepatitis B virus replication in vivo Journal of Virology 2005 79 11 7269 7272 (Pubitemid 40677357)
54. Schwarz K., Storni T., Manolova V., Didierlaurent A., Sirard J. C., Rthlisberger P., Bachmann M. F., Role of toll-like receptors in costimulating cytotoxic T cell responses European Journal of Immunology 2003 33 6 1465 1470 (Pubitemid 36790406)
55. Sung J. J. Y., Chan H. L. Y., HBV-ISS (Dynavax) Current Opinion in Molecular Therapeutics 2006 8 2 150 155
56. Wu J., Lu M., Meng Z., Trippler M., Broering R., Szczeponek A., Krux F., Dittmer U., Roggendorf M., Gerken G., Schlaak J. F., Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice Hepatology 2007 46 6 1769 1778
57. Yerly D., Di Giammarino L., Bihl F., Cerny A., Targets of emerging therapies for viral hepatitis B and C Expert Opinion on Therapeutic Targets 2006 10 6 833 850 (Pubitemid 44816747)